Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 115INDUSTRY 30OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urogenital Neoplasms 1Thymoma 1Stomach Neoplasms 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Liver Neoplasms 1Genital Neoplasms, Female 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Advanced Primary Liver Cancer 1Adrenocortical Carcinoma 1

Interventions

tislelizumab 4Sorafenib 3Propranolol 3ledipasvir 2entecavir 2donafenib 2apatinib 2Sofosbuvir 2Ribavirin 2Radiotherapy 2Proton Therapy 2Bevacizumab 2sitravatinib 1polysaccharide MGN3 1palbociclib 1lenvatinib 1lens intermediate filament proteins 1ledipasvir, sofosbuvir drug combination 1envafolimab 1elbasvir-grazoprevir drug combination 1daclatasvir 1camrelizumab 1atezolizumab 1anlotinib 1Vitamin D 1Urination 1Tyrosine Kinase Inhibitors 1Surgical Procedures, Operative 1Simeprevir 1Raltegravir Potassium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Carcinoma, Hepatocellular × lenvatinib × Clear all
NCT05391867 2022-05-26

Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma

Sir Salimullah Medical College Mitford Hospital

Phase NA Unknown
70 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡